 Sarah Sasse
Concepts (198)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Receptors, Glucocorticoid | 13 | 2025 | 155 | 3.550 |
Why?
| | Dexamethasone | 9 | 2022 | 368 | 2.080 |
Why?
| | Glucocorticoids | 7 | 2025 | 594 | 1.410 |
Why?
| | Transcription, Genetic | 8 | 2025 | 1457 | 1.380 |
Why?
| | Kruppel-Like Transcription Factors | 4 | 2020 | 66 | 1.250 |
Why?
| | Enhancer Elements, Genetic | 5 | 2025 | 190 | 1.180 |
Why?
| | Muscle, Smooth | 3 | 2019 | 155 | 1.140 |
Why?
| | NF-kappa B | 8 | 2025 | 691 | 1.090 |
Why?
| | Tumor Necrosis Factor-alpha | 6 | 2024 | 1242 | 0.970 |
Why?
| | Nuclear Proteins | 3 | 2017 | 712 | 0.790 |
Why?
| | Gene Expression Regulation | 11 | 2025 | 2607 | 0.770 |
Why?
| | Anti-Inflammatory Agents | 2 | 2021 | 496 | 0.640 |
Why?
| | RNA | 2 | 2025 | 921 | 0.610 |
Why?
| | Hyperoxia | 1 | 2019 | 90 | 0.590 |
Why?
| | Proline Oxidase | 2 | 2015 | 6 | 0.580 |
Why?
| | Tumor Necrosis Factor alpha-Induced Protein 3 | 3 | 2016 | 11 | 0.570 |
Why?
| | Response Elements | 2 | 2015 | 91 | 0.560 |
Why?
| | Phospholipase C delta | 1 | 2017 | 5 | 0.560 |
Why?
| | Airway Obstruction | 1 | 2019 | 162 | 0.550 |
Why?
| | Habituation, Psychophysiologic | 4 | 2011 | 55 | 0.540 |
Why?
| | Airway Remodeling | 1 | 2017 | 64 | 0.530 |
Why?
| | Respiratory System | 2 | 2017 | 157 | 0.520 |
Why?
| | Asthma | 3 | 2025 | 2295 | 0.480 |
Why?
| | Saccharopine Dehydrogenases | 1 | 2015 | 3 | 0.480 |
Why?
| | Corticosterone | 5 | 2010 | 236 | 0.460 |
Why?
| | RNA, Messenger | 5 | 2020 | 2833 | 0.450 |
Why?
| | Cytokines | 3 | 2025 | 2085 | 0.450 |
Why?
| | Stress, Psychological | 7 | 2011 | 1100 | 0.440 |
Why?
| | Inflammation | 4 | 2022 | 2837 | 0.440 |
Why?
| | Idiopathic Pulmonary Fibrosis | 4 | 2025 | 657 | 0.440 |
Why?
| | Transcription Factor RelA | 3 | 2025 | 87 | 0.410 |
Why?
| | Receptors, Aryl Hydrocarbon | 2 | 2025 | 55 | 0.400 |
Why?
| | Adrenocorticotropic Hormone | 4 | 2010 | 143 | 0.400 |
Why?
| | Acoustic Stimulation | 5 | 2011 | 312 | 0.400 |
Why?
| | Receptors, Cytoplasmic and Nuclear | 1 | 2014 | 220 | 0.390 |
Why?
| | Basic Helix-Loop-Helix Transcription Factors | 2 | 2025 | 243 | 0.360 |
Why?
| | Epithelial Cells | 5 | 2024 | 1096 | 0.350 |
Why?
| | Transcription Factors | 3 | 2022 | 1719 | 0.340 |
Why?
| | Signal Transduction | 6 | 2021 | 5079 | 0.330 |
Why?
| | Pituitary-Adrenal System | 5 | 2010 | 162 | 0.310 |
Why?
| | DNA-Binding Proteins | 3 | 2014 | 1502 | 0.310 |
Why?
| | Hypothalamo-Hypophyseal System | 5 | 2010 | 197 | 0.310 |
Why?
| | Mucin-5B | 3 | 2022 | 224 | 0.300 |
Why?
| | Polymorphism, Single Nucleotide | 4 | 2025 | 2189 | 0.300 |
Why?
| | Motor Activity | 3 | 2011 | 718 | 0.290 |
Why?
| | Genomics | 3 | 2022 | 795 | 0.270 |
Why?
| | Chromatin Immunoprecipitation | 3 | 2017 | 138 | 0.270 |
Why?
| | Myocytes, Smooth Muscle | 2 | 2019 | 261 | 0.260 |
Why?
| | Binding Sites | 4 | 2021 | 1303 | 0.250 |
Why?
| | Baculoviral IAP Repeat-Containing 3 Protein | 1 | 2025 | 4 | 0.240 |
Why?
| | Inhibitor of Apoptosis Proteins | 1 | 2025 | 49 | 0.240 |
Why?
| | Bronchi | 2 | 2018 | 260 | 0.240 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 2 | 2023 | 1040 | 0.230 |
Why?
| | Protein Binding | 5 | 2020 | 2224 | 0.230 |
Why?
| | I-kappa B Kinase | 1 | 2024 | 55 | 0.220 |
Why?
| | Respiratory Mucosa | 3 | 2025 | 321 | 0.210 |
Why?
| | A549 Cells | 4 | 2025 | 66 | 0.200 |
Why?
| | RNA Polymerase II | 4 | 2021 | 324 | 0.190 |
Why?
| | Cells, Cultured | 4 | 2018 | 4193 | 0.190 |
Why?
| | Humans | 23 | 2025 | 137585 | 0.190 |
Why?
| | Chromatin | 3 | 2022 | 519 | 0.190 |
Why?
| | Wood | 1 | 2021 | 16 | 0.180 |
Why?
| | Promoter Regions, Genetic | 3 | 2017 | 1250 | 0.180 |
Why?
| | Alveolar Epithelial Cells | 1 | 2022 | 114 | 0.180 |
Why?
| | Lung | 6 | 2024 | 4060 | 0.180 |
Why?
| | Models, Genetic | 2 | 2021 | 600 | 0.180 |
Why?
| | Air Pollution | 1 | 2025 | 316 | 0.180 |
Why?
| | Toll-Like Receptor 2 | 1 | 2022 | 115 | 0.180 |
Why?
| | Stress, Physiological | 3 | 2010 | 443 | 0.180 |
Why?
| | Genetic Predisposition to Disease | 3 | 2025 | 2426 | 0.180 |
Why?
| | PPAR gamma | 1 | 2022 | 182 | 0.170 |
Why?
| | Animals | 14 | 2025 | 36940 | 0.170 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 1 | 2022 | 283 | 0.170 |
Why?
| | Smoke | 1 | 2021 | 141 | 0.170 |
Why?
| | Particulate Matter | 1 | 2022 | 315 | 0.160 |
Why?
| | Fluticasone | 1 | 2018 | 90 | 0.150 |
Why?
| | Cell Line | 4 | 2021 | 2847 | 0.150 |
Why?
| | Adrenergic beta-2 Receptor Agonists | 1 | 2018 | 37 | 0.140 |
Why?
| | Drug Resistance | 1 | 2018 | 169 | 0.140 |
Why?
| | Repressor Proteins | 1 | 2021 | 427 | 0.140 |
Why?
| | Base Sequence | 3 | 2017 | 2181 | 0.140 |
Why?
| | Cellular Senescence | 1 | 2019 | 189 | 0.140 |
Why?
| | Hypertrophy | 1 | 2017 | 133 | 0.130 |
Why?
| | Transduction, Genetic | 1 | 2017 | 127 | 0.130 |
Why?
| | Transcriptional Activation | 2 | 2016 | 378 | 0.130 |
Why?
| | Trachea | 1 | 2018 | 237 | 0.130 |
Why?
| | HEK293 Cells | 1 | 2019 | 730 | 0.130 |
Why?
| | Primary Cell Culture | 1 | 2017 | 171 | 0.130 |
Why?
| | Genes, Reporter | 1 | 2017 | 269 | 0.130 |
Why?
| | Adenoviridae | 1 | 2017 | 193 | 0.130 |
Why?
| | Amygdala | 2 | 2009 | 191 | 0.120 |
Why?
| | Fibroblasts | 2 | 2025 | 996 | 0.120 |
Why?
| | Gene Silencing | 1 | 2016 | 195 | 0.120 |
Why?
| | Rats, Sprague-Dawley | 6 | 2011 | 2486 | 0.120 |
Why?
| | Interferon-gamma | 1 | 2018 | 789 | 0.120 |
Why?
| | Electrophoretic Mobility Shift Assay | 1 | 2015 | 86 | 0.120 |
Why?
| | Rats | 8 | 2011 | 5647 | 0.110 |
Why?
| | Adrenal Cortex Hormones | 1 | 2018 | 565 | 0.110 |
Why?
| | Sequence Analysis, RNA | 1 | 2017 | 452 | 0.110 |
Why?
| | Recombinant Fusion Proteins | 1 | 2017 | 665 | 0.110 |
Why?
| | Transforming Growth Factor beta | 1 | 2017 | 480 | 0.110 |
Why?
| | Cohort Studies | 1 | 2025 | 5742 | 0.110 |
Why?
| | Male | 11 | 2025 | 67762 | 0.110 |
Why?
| | Introns | 1 | 2014 | 258 | 0.100 |
Why?
| | Interleukin-1beta | 2 | 2025 | 372 | 0.100 |
Why?
| | Fatty Acid-Binding Proteins | 2 | 2023 | 70 | 0.100 |
Why?
| | Noise | 3 | 2011 | 65 | 0.100 |
Why?
| | Gene Regulatory Networks | 1 | 2014 | 305 | 0.090 |
Why?
| | High-Throughput Nucleotide Sequencing | 1 | 2015 | 539 | 0.090 |
Why?
| | Physical Conditioning, Animal | 2 | 2011 | 257 | 0.090 |
Why?
| | Transcriptome | 1 | 2017 | 971 | 0.090 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2014 | 455 | 0.090 |
Why?
| | Molecular Sequence Data | 1 | 2015 | 2900 | 0.080 |
Why?
| | Nerve Growth Factors | 1 | 2010 | 79 | 0.080 |
Why?
| | Body Temperature | 1 | 2011 | 222 | 0.080 |
Why?
| | Dentate Gyrus | 1 | 2010 | 37 | 0.080 |
Why?
| | Receptors, Adrenergic, alpha-1 | 1 | 2010 | 45 | 0.080 |
Why?
| | Olfactory Perception | 1 | 2009 | 16 | 0.080 |
Why?
| | Escape Reaction | 1 | 2009 | 62 | 0.080 |
Why?
| | Olfactory Pathways | 1 | 2009 | 36 | 0.080 |
Why?
| | Mice | 3 | 2021 | 17787 | 0.080 |
Why?
| | Middle Aged | 2 | 2025 | 33479 | 0.080 |
Why?
| | Analysis of Variance | 5 | 2010 | 1316 | 0.080 |
Why?
| | Adrenal Glands | 1 | 2008 | 78 | 0.070 |
Why?
| | Female | 4 | 2025 | 73304 | 0.070 |
Why?
| | Organ Size | 1 | 2008 | 477 | 0.070 |
Why?
| | Infant, Newborn | 1 | 2019 | 6079 | 0.070 |
Why?
| | Thymus Gland | 1 | 2008 | 312 | 0.070 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 4 | 2010 | 852 | 0.070 |
Why?
| | Heart Rate | 1 | 2011 | 822 | 0.070 |
Why?
| | Epigenesis, Genetic | 2 | 2022 | 660 | 0.070 |
Why?
| | Radioimmunoassay | 3 | 2010 | 173 | 0.060 |
Why?
| | Mice, Knockout | 1 | 2013 | 3015 | 0.060 |
Why?
| | DNA Methylation | 2 | 2022 | 643 | 0.060 |
Why?
| | Gene Expression | 2 | 2022 | 1502 | 0.060 |
Why?
| | Ubiquitin-Protein Ligases | 1 | 2025 | 175 | 0.050 |
Why?
| | Neural Inhibition | 1 | 2005 | 169 | 0.050 |
Why?
| | Transposases | 1 | 2022 | 19 | 0.050 |
Why?
| | Afghanistan | 1 | 2022 | 71 | 0.050 |
Why?
| | Mice, Inbred C57BL | 1 | 2013 | 5757 | 0.050 |
Why?
| | Pulmonary Alveoli | 1 | 2025 | 405 | 0.050 |
Why?
| | Adult | 1 | 2025 | 37929 | 0.050 |
Why?
| | Cytochrome P-450 CYP1A1 | 1 | 2021 | 9 | 0.050 |
Why?
| | Budesonide | 1 | 2022 | 89 | 0.050 |
Why?
| | DNA (Cytosine-5-)-Methyltransferases | 1 | 2021 | 32 | 0.050 |
Why?
| | Cell Line, Transformed | 1 | 2021 | 145 | 0.040 |
Why?
| | NIH 3T3 Cells | 1 | 2021 | 144 | 0.040 |
Why?
| | Gain of Function Mutation | 1 | 2021 | 36 | 0.040 |
Why?
| | Proto-Oncogene Proteins c-ets | 1 | 2021 | 56 | 0.040 |
Why?
| | Respiratory Tract Diseases | 1 | 2022 | 184 | 0.040 |
Why?
| | Chromatin Assembly and Disassembly | 1 | 2021 | 104 | 0.040 |
Why?
| | Quantitative Trait Loci | 1 | 2022 | 380 | 0.040 |
Why?
| | Young Adult | 1 | 2016 | 13209 | 0.040 |
Why?
| | Ferrets | 2 | 2009 | 27 | 0.040 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 2 | 2016 | 976 | 0.040 |
Why?
| | Leukocytes, Mononuclear | 1 | 2022 | 558 | 0.040 |
Why?
| | STAT3 Transcription Factor | 1 | 2021 | 206 | 0.040 |
Why?
| | Odorants | 2 | 2009 | 109 | 0.040 |
Why?
| | Smell | 2 | 2009 | 117 | 0.040 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 2022 | 528 | 0.040 |
Why?
| | Th1 Cells | 1 | 2018 | 143 | 0.040 |
Why?
| | Hepatocyte Nuclear Factor 3-beta | 1 | 2017 | 12 | 0.030 |
Why?
| | Restraint, Physical | 2 | 2010 | 72 | 0.030 |
Why?
| | Delayed-Action Preparations | 1 | 2018 | 181 | 0.030 |
Why?
| | In Situ Hybridization | 2 | 2010 | 316 | 0.030 |
Why?
| | CpG Islands | 1 | 2017 | 157 | 0.030 |
Why?
| | Adolescent | 1 | 2016 | 21513 | 0.030 |
Why?
| | Proto-Oncogene Proteins c-fos | 2 | 2009 | 185 | 0.030 |
Why?
| | Gene Knockdown Techniques | 1 | 2017 | 327 | 0.030 |
Why?
| | Disease Progression | 1 | 2023 | 2757 | 0.030 |
Why?
| | DNA | 1 | 2022 | 1459 | 0.030 |
Why?
| | RNA, Small Interfering | 1 | 2017 | 622 | 0.030 |
Why?
| | RNA Interference | 1 | 2016 | 469 | 0.030 |
Why?
| | Macrophages | 1 | 2022 | 1547 | 0.030 |
Why?
| | Behavior, Animal | 2 | 2009 | 501 | 0.030 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2018 | 2057 | 0.030 |
Why?
| | Blotting, Western | 1 | 2016 | 1226 | 0.030 |
Why?
| | Environment, Controlled | 1 | 2010 | 22 | 0.020 |
Why?
| | Zinc Sulfate | 1 | 2009 | 8 | 0.020 |
Why?
| | Vomeronasal Organ | 1 | 2009 | 7 | 0.020 |
Why?
| | Ibotenic Acid | 1 | 2009 | 5 | 0.020 |
Why?
| | Dominance-Subordination | 1 | 2009 | 16 | 0.020 |
Why?
| | Risk Factors | 1 | 2023 | 10388 | 0.020 |
Why?
| | Olfaction Disorders | 1 | 2009 | 63 | 0.020 |
Why?
| | Cell Count | 1 | 2009 | 324 | 0.020 |
Why?
| | Running | 1 | 2011 | 230 | 0.020 |
Why?
| | Paraventricular Hypothalamic Nucleus | 1 | 2005 | 32 | 0.010 |
Why?
| | Early Growth Response Protein 1 | 1 | 2005 | 27 | 0.010 |
Why?
| | Amphetamine | 1 | 2005 | 35 | 0.010 |
Why?
| | Immunohistochemistry | 1 | 2009 | 1738 | 0.010 |
Why?
| | Immediate-Early Proteins | 1 | 2005 | 49 | 0.010 |
Why?
| | Dose-Response Relationship, Radiation | 1 | 2005 | 141 | 0.010 |
Why?
| | Child, Preschool | 1 | 2018 | 11074 | 0.010 |
Why?
| | Central Nervous System Stimulants | 1 | 2005 | 161 | 0.010 |
Why?
| | Disease Models, Animal | 1 | 2010 | 4295 | 0.010 |
Why?
| | Time Factors | 1 | 2010 | 6828 | 0.010 |
Why?
| | Child | 1 | 2018 | 21935 | 0.010 |
Why?
| | Models, Biological | 1 | 2005 | 1783 | 0.010 |
Why?
|
|
Sasse's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|